Correctly and consistently taking HIV medications has always been important – and even though HIV treatment today is easier to take (and less toxic) than ever, adherence can still be a challenge.
These restrictions have no proven public-health benefit -- and can, in fact, shroud nations in a false sense of assurance that such bans, and not sound health policy, will keep HIV in their countries.
Research on Two Supplements Addresses HIV-Driven Inflammation in the Gut -- A Blog Entry by Jeannie Wraight
"Gastrointestinal (GI) health is proving to be a vital, though often ignored, component of HIV infection."
A person's viral load when he or she first starts HIV medications may at least partly predict his or her chances of long-term treatment success, according to a recent study.
People living with HIV in North America who receive antiretroviral therapy have improving -- near normal, in fact -- life expectancy, according to new data presented at IAS 2013.
Investigators from the NA-ACCORD presented the results of their analys...
Roughly one out of every 13 gay men in a recent study had detectable HIV in their semen but an undetectable viral load in their bloodstream.
Despite generally exciting findings, a new study notes that improvements in life expectancy varied widely by sex, race and other factors.
People with HIV face an increased pneumonia risk even after they've started HIV treatment. However, a recent study suggests that risk isn't affected by how suppressed the immune system was prior to starting treatment.
Even if people start HIV treatment late, they still have a good chance at recovery. However, not everyone benefits equally: For instance, some people seem to have poor CD4 count gains even when HIV meds are working well. New research explores why....
A 20-year-old, HIV-infected individual on treatment who is living in the U.S. or Canada can reasonably expect to live into his or her early 70s, which is slightly lower than the U.S. general average of 78 years, according to a recent study. However, ...